Fig. 4

Survival risk score prediction based on the selected eight-probe in LUAD patients. a The risk score was used to classify 69 TVGH patients in the training cohort into two groups by median (as -2.63) (upper). The Kaplan-Meier overall survival analysis was performed to show the relative median survival time (MST) in two groups identified by the risk score calculation (middle). The 95 % confidence interval of survival time and p values of various methods are shown as indicated (lower). b The risk score, MST, and p values were analyzed in the validation cohort of 299 LUAD patients from TCGA database